Drugmaker Genentech has alerted multiple health systems that issues with their split-billing software may be the source of potential 340B program violations.
Genentech Asks Hospitals to Check 340B Split-Billing Software Settings
Drug manufacturer Genentech has asked health systems and hospitals about possible 340B program compliance violations involving split-billing software settings. Staff [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.